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Title: 
Prospective intra-individual comparison of standard dose versus reduced-dose thoracic CT using 
hybrid and pure iterative reconstruction in a follow-up cohort of pulmonary nodules  Effect of 
detectability of pulmonary nodules with lowering dose based on nodule size, type and body mass 
index. 
 
 
 
 
 
 
 
 
 
 
Abbreviations:  
FBP - filtered back projection 
ASIR- adaptive statistical reconstruction 
MBIR - model-based iterative reconstruction 
STD - standard dose 
RD1  reduced dose 1 
RD2  reduced dose 2  
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ABSTRACT 
Objectives 
To determine the diagnostic accuracy of lung nodule detection in thoracic CT using 2 reduced dose 
protocols comparing 3 available CT reconstruction algorithms (filtered back projection-FBP, adaptive 
statistical reconstruction-ASIR and model-based iterative reconstruction-MBIR) in a western 
population.   
 
Materials and Methods: 
A prospective single-center study recruited 98 patients with written consent. Standard dose (STD) 
thoracic CT followed by 2 reduced-dose protocols using automatic tube current modulation (RD1) 
and fixed tube current (RD2) were performed and reconstructed with FBP, ASIR and MBIR with 
subsequent diagnostic accuracy analysis for nodule detection.   
 
Results: 
108 solid nodules, 47 subsolid nodules and 89 purely calcified nodules were analyzed. RD1 was 
). 
0.739/0.739, for rater 1/rater2 respectively. For subsolid nodule
0.971/0.986 and AUC for RD2 was 0.914/0.914, for rater 1/rater2 respectively. For calcified nodules 
excellent detection accuracy was maintained regardless of reconstruction algorithms with AUC >0.97 
for both readers across all dose and reconstruction algorithms. 
 
Conclusions: 
Diagnostic performance of lung nodule is affected by nodule size, protocol, reconstruction algorithm 
assessment 
 
 
 
 
 
 
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
 
 
Introduction: 
There is evidence that in selected high-risk individuals, low dose computed tomography 
(LDCT) screening significantly reduces lung cancer mortality and all-cause mortality and is 
recommended by many international organizations [1, 2]. However, as outlined by the recent 
Cochrane review, the relative harms and benefits of screening across different risk groups and 
settings needs to be considered and there is a requirement for standardized practices for 
screening with LDCT [3, 4]. The ACR Society of Thoracic Radiology suggests CT 
examinations should be acquired by using multidetector scanners with at least 16 detector 
rows, a helical technique, and with the patient in a suspended state of full inspiration [5]. For 
a standardized patient, it is recommended that the technique should deliver CTDIvol of 
To maximize the risk-benefit ratio in favor of the screened individual, the radiation 
dose should be as low as reasonably achievable without compromising image quality and 
accurate detection but the maximum extent of dose reduction has not yet been established. 
The broad availability of iterative reconstruction algorithms on clinical CT scanners has 
enabled significant potential dose reduction in the context of screening. There are several 
versions of iterative reconstructions. The first generation (hybrid) shows dose reduction in the 
range of 30-40% [6-11]. The second generation iterative reconstruction (pure) has shown 
more dose reduction capability with reported range of 50-80% compared to the traditional 
filtered-back projection (FBP) [12-17]. Recent papers have explored the feasibility of using 
-based iterative reconstruction (MBIR) in the 
context of lung nodule surveillance [18-20]. It has been shown that it is possible to achieve 
meaningful image quality but significant dose reduction was achieved on selected patients 
with low body weight or BMI. In a western population, the average body weight/BMI are 
considerably higher. Currently, there are 2 broad strategies in performing LDCT with regards 
to setting of tube current. Investigators have used either tube current modulation approach or 
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a fixed tube current approach. It is not clear which methods are more reliable in real world 
setting where there is large variation in body size.  
The purpose of our study is to determine the diagnostic accuracy of lung nodule detection in 
thoracic CT using 2 reduced dose protocols using automatic tube current modulation and 
fixed tube current approaches comparing 3 available CT reconstruction algorithms (filtered 
back projection-FBP, adaptive statistical reconstruction-ASIR and model-based iterative 
reconstruction-MBIR) to reference standard-dose thoracic CT in a western population.   
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Materials and Methods 
Study Population 
This prospective single-center study obtained institutional review board approval and 
recruited 98 patients.  Patients were identified from referral to department for a non-contrast 
CT Thorax with a specific indication of follow-up of previously detected lung nodule(s) on a 
prior CT scan. The identified participants were interviewed and on agreement were 
prospectively enrolled consecutively from August 2013  February 2015. Written informed 
consent was obtained on all patients. We follow the previously published Fleischner society 
guidelines for follow-up of solitary pulmonary nodule [21, 22].  
Inclusion and Exclusion criteria 
Inclusion criteria for the study were as follows: age more than or equal to 40 years of age at 
the time of scan, able to provide informed written consent, able to hold their breath for at 
least 20 seconds, able to follow verbal commands for breath holding and remain still for the 
duration of scanning, able to put arms over head for the entirety of the scan. Exclusion 
criteria were as follows: unable to give inform consent, other scan indication (e.g. with 
contrast, CT pulmonary angiogram, etc), unable to put hands over their head. Patient 
demographics (weight, height, and body mass index (calculated by weight / height in meters 
square) and clinical information (e.g. previous thoracic surgery, history of malignancy, 
clinical symptoms) were recorded.  
Imaging Parameters 
All examinations were performed with a 64-row detector CT scanner (Discovery 750 HD; 
GE Healthcare, Wisconsin, USA). No intravenous contrast was given. Standard dose scan 
parameters were as follows: tube voltage 120, rotation time 0.5s, pitch 1.375:1, noise index 
39.6, tube current range 10-750mA. Reduced-dose 1 (RD1) scan parameters were as follows: 
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tube voltage 100, rotation time 0.5s, pitch 1.375:1, noise index 85, tube current range 10-
750mA. Reduced-dose 2 (RD2) scan parameters were as follows: tube voltage 100, rotation 
time 0.5s, pitch 0.984:1, fixed tube current 10mA. All Patients were scanned in a single 
breath-hold.  
Scanning Parameters 
The order of 2 reduced dose scans were randomized after the initial standard of care scan to 
even out the effect of artefact that could inadvertently occur if the patient breathed during 
scanning. It is thought that this would be more likely to occur towards the end of the scan. 
Block randomization method was used to maintain equal numbers in each arm.  
Reconstruction Algorithms 
All patients received 3 scans in total (STD, RD1 and RD2). Each scan was reconstructed with 
FBP, ASIR with 30% blending, and MBIR. For each patient, this generated 9 scans and for 
all patients this generated a total of 882 scans. For the purpose of assessment, standard dose 
with ASIR was used as reference standard because in our center this is in routine clinical use, 
and our standard dose protocol are already optimized for ASIR not FBP.  The remaining 
scans and reconstruction algorithms serve as index tests under evaluation (see Figure 1).  
Radiation Dose 
DLP and CTDIvol were recorded for each scanning series. AP and lateral diameters were 
recorded and by using the conversion factors as per American Association of Physicists 
Medicine (AAPM) guidelines, SSDE was calculated [23]. Effective doses (ED) were also 
estimated using a conversion of 0.014 taken from a normalized value of ED per DLP for 
chest [24].  
Objective Image Assessment 
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Quantitative measurements were performed using advanced open-source PACS workstation 
DICOM viewer (Osirix 3.8.1 on Mac OS, Pixmeo, Geneva, Switzerland) and GE (GE 
Healthcare, Wisconsin, USA) Workstations with dedicated Volume Viewer (v.4.6). Mean CT 
attenuation values (in Hounsfield units) and standard deviation were obtained in three 
consecutive images over the aorta by manually placing a circular region on interests (ROIs) 
which were duplicated to all 9 series. ROIs were copied to identical slices to allow for 
accurate comparison between different dose scans in the same patient at same location. For 
each study, the image noise was measured as the standard deviation of the pixel values drawn 
over the aorta. Signal to noise ratio was calculated by dividing mean HU by mean SD.  
Subjective Image Assessment   
All image data sets were assessed blinded and randomized manner by two experienced 
thoracic radiologists (5 and 8 . Mean scores were calculated for 
each of the reconstructed series. Subjective image quality were assessed in terms of 
subjective image noise, subjective image contrast, artifacts and diagnostic confidence.   
Subjective analysis scoring criteria 
Subjective image noise was assessed using a five-point scale (1 = unacceptable image noise, 
2 = above average noise, 3 = average image noise, 4 = less than average noise, and 5 = 
minimal image noise).  
Image contrast was assessed by using a five-point scale (1= very poor contrast, 2 = 
suboptimal image contrast, 3 = acceptable image contrast, 4 = above average contrast, and 5 
= excellent image contrast).  
Diagnostic confidence was assessed by using a four-point scale (1 = poor confidence, 2 = 
confident only for a limited clinical entity such as a calcified lesion, or a large lesion, 3 = 
probably confident, and 4 = completely confident). Scores for diagnostic confidence was used 
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to subsequently calculate a cut-off threshold for images that were adequate for diagnosis. 
Scores of 1 and 2 were classified as non-diagnostic and scores of 3 and 4 were classified as of 
diagnostic quality.  
Diagnostic Accuracy 
For the diagnostic accuracy assessment, the primary endpoint was the presence or absence of 
pulmonary nodules. The readers were asked to record the presence/absence of nodules per 
lobe basis. The types of nodules were classified as solid (including predominantly solid 
nodule with mixed density containing fat or calcification), purely calcified, or subsolid. One 
reader was asked to view all reconstruction side-by-side, with available clinical information 
and reporting viewed subsequently for consensus with a second reader. This then acted as 
reference standard.  Size (as average of length and width) were measured and based on 
classification of Fleischner society. For solid nodules, they were classified into 4 categories 
-5.9mm, 6-
averaged over the largest diameter of ground glass components and were classified into 2 
Two separate readers (8 and 20  subsequently 
were asked to read the blinded scans one at a time for the purpose of diagnostic accuracy in 
nodule detection. This was done in 18 separate reporting sessions of at least 1 week apart to 
avoid recall bias. Area under curve for each types of nodules were then calculated compared 
with reference standard for each types of nodules, on a per lobe basis. Readers were allowed 
to adjust windowing and use maximum intensity projection as per normal clinical reporting 
practice. No computer aided detection software was used.  
Statistical Analysis 
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Data were analyzed with a statistical software package (Stata 13.1, Stata Corp, Texas, USA). 
Sample size was calculated using 2-tail t-test linear regression model based on 97% power, 
effect size of 0.15 and -probability of 0.05 giving sample size of 98. Quantitative image 
metrics such as objective image noise and CT numbers using analysis of variance (ANOVA). 
 was used to analyze subjective image 
quality and other qualitative lesion assessment parameters. Interobserver variability was 
compared using kappa statistics. Grading was classified as follows: 0.21  0.40: fair 
agreement; 0.41  0.60: moderate agreement, 0.61  0.80: substantial agreement, 0.81  1.00: 
almost perfect agreement. Diagnostic accuracy was calculated by area under curve (AUC), 
with sensitivity and specificity  calculated for nodule detection using ASIR standard dose as 
reference. A p-value of <0.05 was considered statistically significant. 
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Results 
Patient demographics are listed in Table 1. There were 62 men and 38 women. Mean age was 
66.2 (range 43-89). Mean BMI was 28.2 (± 6.5 SD). Radiation dose is listed in Table 2. DLP 
were 235.5, 68.7 and 9.9 mGy.cm for STD, RD1 and RD2 respectively. SSDE were 7.4, 2.1 
and 0.3 mGy for STD, RD1 and RD2 respectively. 
Objective Image Assessment 
There was significant difference between the measured noise across all reconstruction 
algorithms and dose. Compared to standard dose ASIR, FBP shows higher image noise, and 
MBIR shows lower image noise (p<0.05). This is tabulated in Table 3. In terms of 
attenuation values, compared to standard dose ASIR, no significant difference exists between 
different doses and algorithms except for RD2 MBIR (p<0.05). This is tabulated in Table 4. 
We postulate that the reduced mean attenuation values for RD2 MBIR may be due to over 
correction of an otherwise noisy raw images obtained from very low dose scan.   
Subjective Image Assessment   
ASIR STD had the best mean scores but no statistical differences between FBP STD and 
MBIR STD (p>0.05). Statistical significantly poorer scores were seen for reduced dose scans 
across all reconstructions (p<0.05). The scores were worse for RD2 compared to RD1. For 
reduced dose scans, FBP had the worse score compared to other reconstruction algorithms 
(p<0.05). For RD1, MBIR was superior to ASIR (p<0.05). For RD2, MBIR and ASIR were 
not significantly different (p>0.05). For representative images, refer Figure 2-3. Results are 
tabulated in Table 5. Interobserver agreement ranged from moderate to almost perfect (k= 
0.54-0.81 for subjective image noise; k=0.65-0.89 for subjective image contrast; k= 0.54-0.89 
for diagnostic confidence). Diagnostic confidence was further analyzed to identify studies 
that were deemed of diagnostic quality This shows that there is reduced diagnostic 
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acceptability for RD2, and to lesser extent RD1. The diagnostic acceptability was 100% for 
STD dose (FBP, ASIR, MBIR), RD1 (MBIR). This reduced to 98% for RD 1 (ASIR and 
FBP), 91.8% for RD2 (ASIR and MBIR, and most reduced to 85.7% for RD2 (FBP). ) The 
reduced quality was correlated to patients with high BMI (see Figure 4-5).  
Diagnostic Accuracy 
AUC, sensitivity and specificity were calculated and overall detection accuracy is shown in 
Table 6. Further sub-analysis based on lesion size for solid and subsolid nodules were also 
performed and is shown in Table 7-8. The inter-observer agreement was almost perfect and 
was 0.971, 0.973 and 0.981 respectively for solid, subsolid and calcified nodules.   
Solid Nodules: 
-5.9mm: 36, 6-7.9mm: 25, 
24). For solid nodules, excellent detection accuracy was maintained when using standard 
dose regardless of reconstruction algorithms with AUC >0.98 for both readers. For ASIR, 
AUC for RD1 was 0.977/0.963 and AUC for RD2 was 0.917/0.916, respectively for rater 
1/rater2. For FBP, AUC for RD1 was 0.958/0.944 and AUC for RD2 was 0.856/0.841, 
respectively for rater 1/rater2. For MBIR, AUC for RD1 was 0.972/0.958 and AUC for RD2 
was 0.921/0.916, respectively for rater 1/rater2. The detection of nodules were significantly 
impaired for nodules of <4mm (see Figure 6). This was markedly worse for RD2. For ASIR, 
AUC for RD1 was 0.935/0.913 and AUC for RD2 was 0.717/0.717, respectively for rater 
1/rater2. For FBP, AUC for RD1 was 0.913/0.891 and AUC for RD2 was 0.609/0.587, 
respectively for rater 1/rater2. For MBIR, AUC for RD1 was 0.935/0.913 and AUC for RD2 
was 0.739/0.739, respectively for rater 1/rater2. For nodules >4.1mm, detection accuracy was 
maintained at AUC > 0.95 in all cases except for FBP reconstruction of RD1 and RD2.   
Subsolid Nodules: 
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There were a total of 47 35, >5.1mm: 12). For subsolid nodules, 
excellent detection accuracy was maintained when using standard dose regardless of 
reconstruction algorithms with AUC >0.98 for both readers. For ASIR, AUC for RD1 was 
0.979/0.988 and AUC for RD2 was 0.936/0.935, respectively for rater 1/rater2. For FBP, 
AUC for RD1 was 0.947/0.956 and AUC for RD2 was 0.894/0.883, respectively for rater 
1/rater2. For MBIR, AUC for RD1 was 0.979/0.988 and AUC for RD2 was 0.936/0.935, 
respectively for rater 1/rater2.  
The detection of subsolid nodules were mildly impaired for size of <5mm for RD2. For 
ASIR, AUC for RD1 was 0.971/0.986 and AUC for RD2 was 0.914/0.914, respectively for 
rater 1/rater2. For FBP, AUC for RD1 was 0.929/0.943 and AUC for RD2 was 0.857/0.843, 
respectively for rater 1/rater2. For MBIR, AUC for RD1 was 0.971/0.986 and AUC for RD2 
was 0.914/0.914, respectively for rater 1/rater2. For size >5mm, detection accuracy was 
maintained at AUC > 0.99 in all cases.   
Purely Calcified Nodules: 
There were a total of 89 purely calcified nodules. For calcified nodules excellent detection 
accuracy was maintained regardless of reconstruction algorithms with AUC >0.97 for both 
readers across all dose and reconstruction algorithms.  
Analysis according to BMI 
Loss of nodule detection, that was seen in reduced dose scans was further sub classified 
the nodule and this was related to BMI. For RD1, loss of detection was seen in the 2 largest 
patients (BMI 52.4 and 54.7) but only for FBP and ASIR. For RD2 loss of detection was seen 
in 8 largest patients (BMI 38.6-54.7) for ASIR and MBIR and in 12 patients (BMI 32.4-54.7) 
for FBP.     
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Discussion 
Diagnostic performance of lung nodule is affected by nodule size, protocol, reconstruction 
deterioration of RD2 is rela  It is important to be aware that 
in pursuit of low dose, one must not compromise on diagnostic quality. Recent study in chest 
phantom examining detectability of lung nodule at chest radiograph equivalent dose has 
shown overall detection rates of 93.3% with DLP: 9mGy*cm [25]. Their detection rates for 
small 5mm solid nodules were 83.9 % using iterative reconstruction. The dose in this study 
was similar to our RD2 protocol dose.  Our results demonstrate slightly poorer performance 
but this can be explained by the fact that we performed on real patients, many of whom have 
larger body size compared to the phantom model. Several previous studies have been 
performed using ultra low dose chest CT but has 
not been extensively tested [17, 18, 20, 26, 27]. It is known that iterative reconstruction may 
cause impairment in subjective image quality especially at very low doses [26] and is in line 
with our subjective analysis findings.  In our study, the main focus was on the detection of 
nodules in a follow-up cohort. Inclinical practice, one must be acutely aware of the effect of 
 on detection accuracy. For both reduced dose approaches, we have shown 
that there are limits to how far once can reduce the dose. The diagnostic acceptability for 
nodule detection subjectively was reduced when tube current modulation approach was used 
at BMI > 52, whereas for the fixed approach this was at BMI > 38. This is further confirmed 
when loss of nodule detection was further subclassified based on BMI. These BMIs appear to 
be the rough estimation of ceiling limits for both approaches in our study, but it must be 
noted that only small number of patients were scanned in our study with high BMI (BMI>50: 
n=2; BMI>38: n=8). Further studies with more patients at high BMI range will be required to 
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reach proper conclusion. In further analysis based on nodule size, we have shown that the 
accuracy is impaired mostly in solid nodules of 4mm. Accuracy for solid nodules > 4.1mm, 
subsolid nodules, and purely calcified nodules have AUC > 0.91. The exception is FBP RD2 
for 5mm subsolid nodules where AUC is 0.857/0.843. The reason for this may be that the 
detection of small subsolid nodules is also heavily influenced by increased image noise which 
is most prominent with FBP RD2. The reduced diagnostic accuracy for solid nodules <4mm 
is in line with previous findings on a different iterative reconstruction technique at similar 
dose [28]. By using the RD1, AUCs for FBP and ASIR even for small solid nodules 4mm 
are reasonable with AUC for ASIR RD1 was 0.935/0.913 and FBP RD1 was 0.913/0.891 
respectively for each rater. So even for centers without the latest pure iterative reconstruction, 
one may still be able to achieve significant dose reduction without significant compromise on 
accuracy. It is important to be aware of the limit of detection accuracy in a technique and 
clinical indication of a test will determine the level at which one can afford to set a threshold 
limit. In the context of pulmonary nodule follow-up for suspected pulmonary metastasis in 
patients who has a history of malignancy, accurate detection is needed regardless of size, as 
detection no matter how small is likely to lead to change in management. In the context of 
lung cancer screening, there is now increasing evidence that detection of nodules < 5mm for 
example from the NELSON trial, no follow up is needed as these nodules are not predictive 
of lung cancer with low probability similar to individuals without nodules [29]. Therefore in 
this context, one may rightly choose to obviate the need for detection of small clinically 
irrelevant nodules.   
There are several limitations in our study. First, our gold standard is nodule detected on 
standard dose ASIR. We have no pathological proof of clinical significance, but for the 
purpose of diagnostic accuracy study, our gold standard is that of an accepted reference test 
now in use in routine clinical practice. Second, although studies were analyzed in a blinded 
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manner, it was noted that MBIR images have unique appearances, so complete blinding was 
difficult, nevertheless steps were made to present image datasets in a randomized manner and 
all identifiable information removed. Third, we set out to examine differences between 
automatic tube current modulation and fixed current approaches. We did not alter protocols 
based on BMI but results from this work will give guidance to future studies that may 
incorporate BMI into protocols. Fourth, we acknowledged that the study design requires an 
increase in radiation exposure to the patient, but the incremental increase was on average 
around 33% increase from average dose, and this was deemed acceptable from our ethics 
board of approval.  
Conclusion: 
In conclusion, we have shown in our study that the detection accuracy will drop significantly 
if a  approach is used either using the fixed tube current or the tube current 
modulation approaches. Being aware of the limitation boundary of low dose approaches will 
ensure that diagnostic accuracy of nodule detection will not be affected which must be based 
on individual patients and clinical indication as we move our imaging protocols towards the 
era of personalized medicine. Individualization of CT protocols taking into account detection 
accuracy limits based on nodule type/size, standard/low dose setting, reconstruction 
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Figure Legends: 
Figure 1. Flow chart demonstrating scan order sequence. All patients received 3 scans in total and 
each scan was reconstructed with filtered-back projection (FBP), adaptive statistical iterative 
reconstruction (ASIR) with 30% blending, and model-based iterative reconstruction (MBIR). For each 
patient, this generated a total of 9 scans. Standard dose with ASIR was used as reference standard. 
The remaining scans and reconstruction algorithms serve as index tests under evaluation. The order of 
the 2 reduced dose scans were randomized after the initial standard of care scan.  
Figure 2. Example of 4mm nodule in female patient with BMI 33. Despite small size, the nodules 
were conspicuous on all reconstruction and doses. A-STD FBP; B-STD ASIR; C-STD MBIR; D-RD1 
FBP; E-RD1 ASIR; F-RD1 MBIR; G-RD2 FBP; H-RD2 ASIR; I-RD2 MBIR 
Figure 3. Example of 6mm ground glass nodule in male patient with BMI 31 which were conspicuous 
on all reconstruction and doses but less clear on RD2. A-STD FBP; B-STD ASIR; C-STD MBIR; D-
RD1 FBP; E-RD1 ASIR; F-RD1 MBIR; G-RD2 FBP; H-RD2 ASIR; I-RD2 MBIR 
Figure 4. Example of 3mm solid nodule in male patient BMI 33 just barely perceptible on MBIR 
RD2 but not in other RD2 images. A-STD FBP; B-STD ASIR; C-STD MBIR; D-RD1 FBP; E-RD1 
ASIR; F-RD1 MBIR; G-RD2 FBP; H-RD2 ASIR; I-RD2 MBIR 
Figure 5. Example of 2mm solid nodule in female patient BMI 54 which was not seen on RD2. A-
STD FBP; B-STD ASIR; C-STD MBIR; D-RD1 FBP; E-RD1 ASIR; F-RD1 MBIR; G-RD2 FBP; H-
RD2 ASIR; I-RD2 MBIR 
Figure 6. Example of several sub 4mm solid nodules in male patient BMI 52 which were less 
conspicuous on RD2. A-STD FBP; B-STD ASIR; C-STD MBIR; D-RD1 FBP; E-RD1 ASIR; F-RD1 
MBIR; G-RD2 FBP; H-RD2 ASIR; I-RD2 MBIR 
 
 






